Journals / 7tepe Klinik / 2018 / Cilt: 14 - Sayı: 2

The effects of antiplatelet drugs and nonsterid anti-inflammatory drugs on postoperative bleeding. Which one we should be afraid of?

Antiagregan ilaçlar ve nonsteroid antienflamatuar ilaçların postoperatif kanama üzerine etkileri. Hangisinden korkmalıyız?

Pages
125–130
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Surveys show that; perioperative NSAIDs or antiplatelet use does not increase the risk of severe bleeding complications and that bleeding is well manageable with local hemostatic methods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Antiplatelet drugs inhibit the aggregation of platelets.
📊
Key Findings & Data:With a reduced risk of thromboembolic events, they increase the risk of bleeding associated with surgical procedures.
💡
Conclusion & Impact:Surveys show that; perioperative NSAIDs or antiplatelet use does not increase the risk of severe bleeding complications and that bleeding is well manageable with local hemostatic methods.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Antiplatelet drugs inhibit the aggregation of platelets. With a reduced risk of thromboembolic events, they increase the risk of bleeding associated with surgical procedures. In patients who use antiplatelets, bleeding during and after oral surgery can be controlled by local hemostatic methods. Interruption of antiplatelet therapy increases the risk of thromboembolic events. For this reason, researchers find it unnecessary to interrupt antiplatelet drugs before oral surgery. Non-steroidal anti-inflammatory drugs (NSAIDs) have analgesic, antipyretic and antiinflammatory effects. They can be used for post-operative analgesia. However, they inhibit the aggregation of platelets so slow the hemostasis and prolong the duration of bleeding. In healthy individuals using NSAIDs, bleeding time generally does not exceed the upper limit of normal bleeding time interval. Both antiplatelet drugs and NSAIDs prolong bleeding time. As a result of the literature review, there was no difference between the effects of antiplatelet drugs and NSAIDs on bleeding. Surveys show that; perioperative NSAIDs or antiplatelet use does not increase the risk of severe bleeding complications and that bleeding is well manageable with local hemostatic methods.

Özet

Antiagregan ilaçlar, trombositlerin agregasyonlarını inhibe eden ilaçlardır. Tromboembolik olay riskinde azalma ile birlikte, cerrahi prosedürler ile bağlantılı kanama riskinde artışa neden olurlar. Antiagregan kullanan hastalarda oral cerrahi sırasında ve sonrasında kanama, lokal hemostatik yöntemlerle kontrol altına alınabilir düzeydedir. Antiagregan tedavinin kesilmesi, tromboembolik olay riskini artırır. Bu nedenle araştırmacılar, oral cerrahi öncesi antiagregan ilaçların kesilmesini gereksiz bulmaktadır. Non-steroid antienflamatuvar ilaçlar (NSAİİ’ler); analjezik, antipiretik ve antienflamatuar etkili ilaçlardır. Ameliyat sonrası analjezi için kullanılabilirler. Ancak trombositlerin agregasyonunu inhibe etmeleri nedeniyle hemostazı yavaşlatırlar ve kanama süresini uzatırlar. NSAİİ kullanan sağlıklı bireylerde kanama zamanı genellikle normal kanama zamanı aralığının üst sınırını geçmez. Antiagregan ilaçlar ve NSAİİ’lerin her ikisi de kanama zamanını uzatır. Yapılan literatür taraması sonucunda, antiagregan ilaçlar ile NSAİİ’lerin kanamaya etkileri arasında farklılık bulunmamıştır. Araştırmalar; perioperatif NSAİİ veya antiagregan kullanımının şiddetli kanama komplikasyonu riskini artırmadığını, oluşan kanamaların lokal hemostatik yöntemlerle iyi yönetilebilir nitelikte olduğunu göstermektedir.

🔖

Cite This Article

ŞİTİLCİ, T., CAN, K., YALTIRIK, M. (2018). The effects of antiplatelet drugs and nonsterid anti-inflammatory drugs on postoperative bleeding. Which one we should be afraid of?. 7tepe Klinik, Cilt: 14 - Sayı: 2, 125–130. https://ajindex.com/articles/150058

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Ghantous AE, Ferneini EM. Aspirin, Plavix and Other Antiplatelet Medications What the Oral and Maxillofacial Surgeon Needs to Know. Oral Maxillofacial Surg Clin N Am 2016; 28: 497-506.
  2. Dinkova A, Kirova D, Delev D. Dental Management and Bleeding Complications of Patients on Long-term Oral Antiplatelet Therapy J of IMAB 2013; 19: 298-304. Kayaalp SO. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. 10.Baskı,
  3. Ankara, Feryal Matbaacılık, 2002. Cañigral A, Silvestre FJ, Cañigral G, Alós M, Garcia-Herraiz A, Plaza A. Evaluation of bleeding risk and measurement methods in dental patients. Med Oral Patol Oral Cir Bucal 2010; 15: 863-868. Furst DE. Are There Differences Among Nonsteroidal Antinflammatory Drugs. Arthritis Rheum 1994; 37: 1-9. Dogne JM, de Leval X, Benoit P, Delarge J, Masereel B, David JL. Recent Advances in Antiplatelet Agents. Curr Med Chem. 2002; 9: 577-589.
  4. Howland RD, Mice MJ Lippincott’s Illustrated Reviews: Farmakoloji. 3. Baskı,
  5. İstanbul, Nobel matbacılık; 2006.
  6. Scully C, Wolff A. Oral Surgery In Patients On Anticoagulant Therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 57-64 O’Gara PT,. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61: 78-140. Jneid H,. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-STelevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2012; 126: 875-910.
  7. Sayıner ZA, Seyyar M, Subari S, Gündoğan E, Yılmaz M. Genel Cerrahi ve Lokal Hemostaz. Turkiye Klinikleri J Hematol-Special Topics 2015; 8: 22-26. Şahna E. Antitrombotik İlaçlar. Türkiye Klinikleri J Cardiol-Special Topics 2009; 2; 67-85.
  8. Angiolillo Dj, Bates Er, Bass Ta: Clinical Profile Of Prasugrel, A Novel Thienopyridine. Am Heart J 2008; 156: 16-22. Johnston S. A New Generation of Antiplatelet and Anticoagulant Medication and the Implications for the Dental Surgeon. Dental Update 2015; 42: 840-854.
  9. Pickering AE, Bridge HS, Nolan J, Stoddart PA. Double-Blind, placebo-controlled analgesic study of ibuprofen or rofecoxib in combination with paracetamol for tonsillectomy in children. British Journal of Anaesthesia 2002; 88: 72-77. Inhibition of p